Macrophage PPARγ is required for normal skeletal muscle and hepatic insulin sensitivity and full antidiabetic effects of thiazolidinediones

被引:395
作者
Hevener, Andrea L.
Olefsky, Jerrold M.
Reichart, Donna
Nguyen, M. T. Audrey
Bandyopadyhay, Gautarn
Leung, Ho-Yin
Watt, Matthew J.
Benner, Chris
Febbraio, Mark A.
Nguyen, Anh-Khoi
Folian, Brian
Subramaniam, Shankar
Gonzalez, Frank J.
Glass, Christopher K.
Ricote, Mercedes
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Div Endocrinol Diabet & Hypertens, Dept Med, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, Dept Cellular & Mol Med, Los Angeles, CA 90095 USA
[3] Univ Melbourne, Dept Med, St Vincents Inst Med Res, Fitzroy, Vic 3065, Australia
[4] Univ Calif San Diego, Dept Bioengn, La Jolla, CA USA
[5] Baker Heart Inst, Cellular & Mol Med Lab, St Kilda, Vic, Australia
[6] NCI, Lab metab, Bethesda, MD USA
[7] Ctr Nacl Invest Cardiovasc, Madrid, Spain
关键词
D O I
10.1172/JCI31561
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
PPAR gamma is required for fat cell development and is the molecular target of antidiabetic thiazolidinediones (TZDs), which exert insulin-sensitizing effects in adipose tissue, skeletal muscle, and liver. Unexpectedly, we found that inactivation of PPAR gamma in macrophages results in the development of significant glucose intolerance plus skeletal muscle and hepatic insulin resistance in lean mice fed a normal diet. This phenotype was associated with increased expression of inflammatory markers and impaired insulin signaling in adipose tissue, muscle, and liver. PPAR gamma-deficient macrophages secreted elevated levels of factors that impair insulin responsiveness in muscle cells in a manner that was enhanced by exposure to FFAs. Consistent with this, the relative degree of insulin resistance became more severe in mice lacking macrophage PPAR gamma following high-fat feeding, and these mice were only partially responsive to TZD treatment. These findings reveal an essential role of PPAR gamma in macrophages for the maintenance of whole-body insulin action and in mediating the antidiabetic actions of TZDs.
引用
收藏
页码:1658 / 1669
页数:12
相关论文
共 61 条
[1]   Conditional disruption of the peroxisome proliferator-activated receptor γ gene in mice results in lowered expression of ABCA1, ABCG1, and apoE in macrophages and reduced cholesterol efflux [J].
Akiyama, TE ;
Sakai, S ;
Lambert, G ;
Nicol, CJ ;
Matsusue, K ;
Pimprale, S ;
Lee, YH ;
Ricote, M ;
Glass, CK ;
Brewer, HB ;
Gonzalez, FJ .
MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (08) :2607-2619
[2]   DETERMINATION OF COENZYME A AND ACETYL COA IN TISSUE EXTRACTS [J].
ALLRED, JB ;
GUY, DG .
ANALYTICAL BIOCHEMISTRY, 1969, 29 (02) :293-+
[3]   IKK-β links inflammation to obesity-induced insulin resistance [J].
Arkan, MC ;
Hevener, AL ;
Greten, FR ;
Maeda, S ;
Li, ZW ;
Long, JM ;
Wynshaw-Boris, A ;
Poli, G ;
Olefsky, J ;
Karin, M .
NATURE MEDICINE, 2005, 11 (02) :191-198
[4]  
Barash Y., 2001, Algorithms in Bioinformatics. First International Workshop, WABI 2001. Proceedings (Lecture Notes in Computer Science Vol.2149), P278
[5]   Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB [J].
Cai, DS ;
Yuan, MS ;
Frantz, DF ;
Melendez, PA ;
Hansen, L ;
Lee, J ;
Shoelson, SE .
NATURE MEDICINE, 2005, 11 (02) :183-190
[6]  
CASTELEIJN E, 1988, J BIOL CHEM, V263, P2699
[7]   Characterizing the effects of saturated fatty acids on insulin signaling and ceramide and diacylglycerol accumulation in 3T3-L1 adipocytes and C2Cl2 myotubes [J].
Chavez, JA ;
Summers, SA .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2003, 419 (02) :101-109
[8]   Conditional gene targeting in macrophages and granulocytes using LysMcre mice [J].
Clausen, BE ;
Burkhardt, C ;
Reith, W ;
Renkawitz, R ;
Förster, I .
TRANSGENIC RESEARCH, 1999, 8 (04) :265-277
[9]   PATHOGENESIS OF NIDDM - A BALANCED OVERVIEW [J].
DEFRONZO, RA ;
BONADONNA, RC ;
FERRANNINI, E .
DIABETES CARE, 1992, 15 (03) :318-368
[10]   THE EFFECT OF INSULIN ON THE DISPOSAL OF INTRAVENOUS GLUCOSE - RESULTS FROM INDIRECT CALORIMETRY AND HEPATIC AND FEMORAL VENOUS CATHETERIZATION [J].
DEFRONZO, RA ;
JACOT, E ;
JEQUIER, E ;
MAEDER, E ;
WAHREN, J ;
FELBER, JP .
DIABETES, 1981, 30 (12) :1000-1007